# To Determine the Safety and Immunogenicity of an Oral Whole Cell ShanChol Cholera Vaccine in Bangladesh

> **NCT01042951** · PHASE2 · COMPLETED · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 330 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** ShanChol Cholera Vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01042951
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-08
- **Final completion:** 2010-11
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2014-10-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01042951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01042951, "To Determine the Safety and Immunogenicity of an Oral Whole Cell ShanChol Cholera Vaccine in Bangladesh". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01042951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*